tiprankstipranks
Trending News
More News >
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
US Market
Advertisement

Jazz Pharmaceuticals (JAZZ) Drug Pipeline

Compare
1,784 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Carboplatin, Paclitaxel, Docetaxel, Zanidatamab, Trastuzumab, Pertuzumab
Breast Cancer, Her2-Positive Breast Cancer
Phase II
Not Yet Recruiting
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Jul 28, 2025
Jzp441
Narcolepsy
Phase I
Recruiting
A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1
Apr 29, 2025
Zanidatamab
Colorectal Cancer, Endometrial Cancer, Non-small Cell Lung Cancer, Ovarian Cancer, Breast Cancer, Pancreatic Cancer, Gastric Cancer, Esophageal Cancer, Gastroesophageal Cancer, Urothelial Carcinoma, Salivary Gland Cancer, Her-2 Protein Overexpression
Phase II
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Nov 16, 2024
Gemcitabine, Zanidatamab, Capecitabine, Vinorelbine, Trastuzumab, Eribulin
Metastatic Her2-Positive Breast Cancer
Phase III
Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
May 24, 2024
Gemcitabine, Cisplatin, Durvalumab, Pembrolizumab, Zanidatamab
Biliary Tract Cancer
Phase III
Recruiting
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Feb 21, 2024
Pembrolizumab, Jzp898
Metastatic Solid Tumor, Advanced Solid Tumor
Phase I
Recruiting
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Oct 19, 2023
Jzp258 (Xywav)
Narcolepsy, Idiopathic Hypersomnia
Phase IV
Completed
A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy
May 16, 2023
Jzp258
Narcolepsy
Phase IV
Completed
A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy
May 12, 2023
Cannabidiol Oral Solution [Epidiolex]
Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
Phase IV
Active Not Recruiting
A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex
May 09, 2023
Jzp541
Autism Spectrum Disorder, Irritability Associated With Autism Spectrum Disorder, Asd
Phase II
Withdrawn
A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder
Feb 08, 2023

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Jazz Pharmaceuticals (JAZZ) have in its pipeline
      JAZZ is currently developing the following drugs: Carboplatin, Paclitaxel, Docetaxel, Zanidatamab, Trastuzumab, Pertuzumab, Jzp441, Zanidatamab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis